Retail News CRM

Tag: initial public offerings

  • OpenAI Seeks 30 Billion Dollar Round Ahead of Anthropic Public Listing

    OpenAI Seeks 30 Billion Dollar Round Ahead of Anthropic Public Listing

    OpenAI is seeking to raise about $30 billion at a valuation exceeding $1.4 trillion. It plans to close the deal before rival Anthropic lists its shares in mid-November.

    The fast-tracked funding round would give the ChatGPT developer fresh private capital. It would also cut off investor cash flows destined for Anthropic’s public market debut.

    SoftBank Group, Abu Dhabi investment vehicle MGX and other existing shareholders are in active discussions to take part. Talks have moved quickly. They follow meetings OpenAI held with sovereign wealth funds and long-only institutions in mid-October. That push coincided directly with Anthropic’s own institutional investor presentations in New York.

    Rushing to Price Private Equity

    Frontier artificial intelligence labs are competing for a narrow group of institutional allocators. Few funds have deep enough pockets to back trillion-dollar balance sheets. By pricing a private round now, OpenAI can lock in multi-billion-dollar allocations. Otherwise, those budgets could go to Anthropic’s IPO order book.

    Private capital also insulates OpenAI if broader equity turbulence pushes its target 2027 listing date further back. Huge compute commitments require continuous cash injections. Data center buildouts demand heavy upfront hardware prepayments. Raising privately lets the company set terms without facing quarterly public market scrutiny.

    Asian technology investors and institutional funds face a sharp split in capital allocation. SoftBank and Gulf sovereign funds have poured tens of billions into Western foundation models. Debt burdens across AI infrastructure providers are prompting stricter risk assessments. If private valuations outpace public multiples, later-stage backers risk holding illiquid shares priced well above what public markets will tolerate.

    Revenue Claims and Accounting Disputes

    OpenAI pitched prospective investors on expanding revenue following the rollout of its GPT-6 Astra model. Annualized revenue hit $50 billion. The company expects that run rate to reach $70 billion by the end of the year.

    To support adoption, the lab cut prices on smaller models and told investors it intends to reduce inference costs further. In contrast, Anthropic reported third-quarter revenue of $16.8 billion, up from $11.6 billion in the second quarter. It reached an annualized run rate of roughly $65 billion by July. Slower month-to-month growth has led some pre-IPO investors to push Anthropic’s valuation down toward $1.5 trillion, below an earlier $2 trillion target.

    Accounting methodologies remain a primary friction point between both camps. OpenAI calculates revenue on a net basis after deducting partner shares. It claims Anthropic inflates top-line figures by booking gross sales processed through cloud distribution partners. Anthropic maintains that its revenue reporting strictly follows standard accounting rules.

    “OpenAI could want to set its own valuation and not have to worry about a comp (comparison),” said Edward Best, co-chair of capital markets at Willkie Farr & Gallagher. “It’s really a two-horse race in terms of being public.”

    Infrastructure Costs Rattling Public Markets

    Heavy spending on AI infrastructure is rattling public exchanges. The Philadelphia Semiconductor Index lost $1.6 trillion in market capitalization in October. Debt-heavy cloud suppliers have faced steep sell-offs.

    Specialized cloud provider CoreWeave saw its debt and equity drop after investors questioned nearly $50 billion in borrowings tied to data center expansion. That volatility has halted listings across the technology sector. Nuclear power developer Holtec withdrew its US offering in September. Blackstone-backed AirTrunk REIT, Nvidia-backed Firmus and SoftBank-backed SB Energy have all postponed or abandoned planned market debuts.

    Valuation Escalation Since March

    In March, OpenAI raised a record $122 billion round that valued the business at $852 billion. That transaction included a commitment of up to $50 billion from Amazon.

    Anthropic now heads into its November listing window while managing investor feedback on third-quarter growth metrics. OpenAI aims to wrap its $30 billion private round before those public regulatory filings reveal full comparative numbers across both balance sheets.

  • Singapore Needs Capital Injections Beyond $6.5 Billion EQDP, SGX Chairman Says

    Singapore Needs Capital Injections Beyond $6.5 Billion EQDP, SGX Chairman Says

    Singapore Exchange chairman Koh Boon Hwee said the domestic stock market lacks flow and liquidity, leaving local investors unwilling to take risks on home-grown shares.

    Speaking on the sidelines of the Forbes Global CEO Conference on Oct 8, Koh noted that further capital injections will be needed to sustain demand, even as the government allocates $6.5 billion through the Equity Market Development Programme. However, he warned that state injections are not a natural, lasting flow like pension-backed markets in the US.

    Koh pointed out that younger Singapore investors have an appetite for risk when buying volatile overseas stocks like Tesla and loss-making SpaceX, but local initial public offerings struggle for traction after listing.

    The Exit Route Problem For Growth Firms

    Early-stage venture funding finds solid support in Singapore. Even so, early backers need domestic public markets to absorb later-stage equity. Thin local trading volume forces founders abroad to provide exits for their investors.

    Regional technology leaders repeatedly bypass the local exchange. Shopee parent Sea listed on the New York Stock Exchange in 2017. Ride-hailing group Grab completed a Nasdaq debut in 2021 through a blank-check combination. In October, Singapore-headquartered data centre developer DayOne filed for a Nasdaq initial public offering, continuing the flow of domestic tech assets to the United States.

    Pension Flow Versus Injections

    State-backed interventions do not generate the structural momentum of institutional retirement pools. Equities in the United States draw on multiple independent pension systems. These funds constantly deploy fresh capital across public listings, private equity, and venture funds.

    The 6.5 billion Singapore dollar injection under the EQDP commits capital without creating an automatic mechanism for ongoing demand. Koh noted that the state fund is invested rather than spent. Standalone allocations leave unresolved questions about long-term reinvestment.

    “Our challenge right now is to create something that is circular and sustainable,” said Koh.

    Supply Chain Concentration Risks

    Capital concentration in Singapore tilts heavily toward established lenders, industrial landlords, and real estate investment trusts. These blue-chip counters trade steadily. Their sheer scale makes rapid compound expansion difficult to maintain over decades.

    Backing younger firms offers a route to build consumer-facing companies with proprietary brand equity rather than component suppliers. Tiered supply chains leave component makers vulnerable to sharp order swings. A 5 per cent order cut from a consumer brand can trigger a 15 per cent revenue decline down the manufacturing chain.

    Domestic Valuation Gaps

    A wide gap between private seed financing and public market liquidity leaves founders with few domestic exit options. If the local exchange cannot provide secondary buyers for high-growth enterprises, early venture capital remains locked abroad once portfolio companies exit in New York or Hong Kong.

    The Monetary Authority of Singapore and SGX have reviewed measures to encourage regional listings, while market participants watch DayOne’s pending Nasdaq filing for final pricing terms.

  • Seven China IPOs Hand Retail Investors over 100,000 Yuan This Year

    Seven China IPOs Hand Retail Investors over 100,000 Yuan This Year

    China’s boom in initial public offerings has handed individual investors first-day trading profits exceeding 100,000 yuan ($14,900) across seven separate stock debuts this year.

    The run represents the most six-figure retail listing windfalls in at least six years. Investors who secured standard 500-share allocations and sold on debut day captured gains equivalent to six months of salary in a single day.

    Robotics and Tech Lead the Surge

    Individual investor Stacy Wei earned about 380,000 yuan after securing an allocation in the listing of Unitree Robotics and selling on debut day, enough to upgrade to her dream car.

    Hardware manufacturers and artificial intelligence supply-chain companies continue to draw the heaviest speculative retail subscriptions across domestic exchanges. Bidders flip shares instantly rather than holding long positions, treating mainland debut pops as liquidity events rather than valuation anchors.

    Shifting Liquidity in Mainland Markets

    Institutional allocators face a different calculation. While retail flippers bank quick cash, fund managers buying secondary tranches absorb the risk of sharp post-debut pullbacks once initial euphoria clears from the order book.

    Sellers who take profits on opening day bypass subsequent price volatility. That trading pattern concentrates quick consumer liquidity in Tier 1 and Tier 2 cities, diverting trading gains directly into private purchases and big-ticket household spending.

    The Trajectory of New Offerings

    Regulators spent recent quarters calibrating the pace of new equity issuance to stabilise broader secondary market indices. That restricted pipeline funnelled intense speculative capital into the select batch of tech and robotics candidates cleared for listing.

    Trading desks now track subscription ratios for the next pipeline of advanced manufacturing and consumer tech filings scheduled for domestic exchange review this autumn.

  • Asia OneHealthcare Plans RM7 Billion Malaysia IPO at RM30 Billion Valuation

    Asia OneHealthcare Plans RM7 Billion Malaysia IPO at RM30 Billion Valuation

    Asia OneHealthcare plans to raise up to RM7.5 billion in a Kuala Lumpur initial public offering in the first quarter of 2027.

    The listing would value the hospital operator at roughly RM30 billion. That valuation would make it one of Southeast Asia’s largest healthcare floats.

    Malaysian billionaire Quek Leng Chan’s Hong Leong Group and US private equity firm TPG back the company. It aims to raise between RM7 billion and RM7.5 billion (US$1.7 billion to US$1.9 billion), with offering documentation due in November.

    Valuation and Asset Footprint

    Formerly known as Columbia Asia Healthcare, the group runs 23 private hospitals across Malaysia and Vietnam. The business serves mid-to-upper income urban households seeking shorter wait times and specialist care outside state systems.

    Private hospital valuations across Southeast Asia trade at high multiples because patient demand holds up across economic cycles. Rising incomes and an ageing middle class in both core markets secure bed occupancy and strong pricing power.

    Private Equity Exit Pipeline

    For TPG and Hong Leong, the deal offers a clean exit path after years of buying regional healthcare assets. Hospital networks provide predictable revenues. Institutional investors understand the cash flows without complex forecasting models.

    The float’s size will test liquidity on Bursa Malaysia, where multi-billion-dollar listings remain rare. A clean debut at the targeted RM30 billion valuation would set a high bar for rival hospital operators weighing listings in Singapore or Jakarta.

    The Rebranding Step

    This share sale follows the group’s restructuring and transition from Columbia Asia to Asia OneHealthcare. That revamp combined its regional clinical operations, digital patient records, and procurement networks under one umbrella across Malaysia and Vietnam.

    Advisers will distribute formal offering documents in November, leading into institutional bookbuilding and final pricing ahead of the early 2027 market debut.

  • Indian Companies Raise 22,400 Crore Rupees as Listing Risks Mount

    Indian Companies Raise 22,400 Crore Rupees as Listing Risks Mount

    Indian companies raised about 22,400 crore rupees through initial public offerings in August as issuers accelerated listings across Mumbai exchanges.

    The rush comes before September 30, when one-year approvals granted by the Securities and Exchange Board of India lapse for a large batch of listing candidates.

    Trading performance has weakened as issue volumes expanded. The share of initial public offerings closing below their issue price on debut day climbed to 37 per cent in 2026 through August 26, up from 33 per cent across 2025. About 40 per cent of all companies listed on Indian bourses since 2022 traded below their offer prices as of late August.

    Valuation Spikes and Pre-IPO Trimming

    Market analysts point to aggressive pricing and short-term cost cuts in draft prospectuses. Issuers frequently compress advertising budgets and headcount spending in the final quarters before filing, lowering visible losses before public scrutiny begins.

    Pre-IPO share transactions also show sharp price differences over short periods. Stock changing hands six months before an issue at half the public offer price raises immediate questions about whether underlying business performance changed enough to justify the markup.

    If existing investors are simply using the IPO to exit, that may not augur well, because the basic premise is that the company should make productive use of the capital.

    Governance risks documented in offer filings include heavy related-party transactions, frequent promoter business pivots, and contingent liabilities that sit off the balance sheet until tax or legal disputes resolve. Recurring negative operating cash flows alongside stated book profits remain a primary warning sign for retail portfolios.

    Loss-Making Consumer Tech Issuers Face Scrutiny

    Across regional equity markets from Seoul to Mumbai, high-multiple listings without clear profit pathways face stricter institutional discounting once trading opens. RetailNews Asia has tracked a similar reassessment across Southeast Asian consumer tech listings, where public investors demand positive unit economics rather than gross merchandise volume growth.

    For loss-making consumer tech businesses now entering Indian exchanges, assessing valuation relies heavily on private venture benchmarks rather than stable price-to-earnings metrics. Comparing prospective valuations against established listed peers in the same sector exposes whether promoters priced the issue for market sentiment rather than underlying returns on capital.

    Attention now turns to the final batch of filings facing the September 30 regulatory deadline, which will test whether institutional books clear remaining supply before clearances expire.